Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Hermann Requardt Biography and Net Worth

Director of Bruker

Dr. Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to February 2015 he served as Chief Executive Officer of the healthcare division of Munich, Germany-based Siemens AG. He also served as Chief Technology Officer of Siemens AG from 2008 through 2011. Additionally, from 2006 through January 2015, he was a member of the Siemens AG Managing Board, during which time he also held a variety of regional and operational responsibilities at Siemens AG and its affiliates. Dr. Requardt joined Siemens AG Medical Solutions in 1984 and served there in roles of increasing responsibility before assuming global responsibility for the magnetic resonance business unit in 1994. Dr. Requardt is an honorary Professor of Physics at the University of Frankfurt and serves on several academic and industrial boards in Germany, including, among other roles, as Vice President of acatech, the National Academy of Science and Engineering. He also is a member of the Advisory Board of Dekra SE, headquartered in Stuttgart, Germany, and the Supervisory Board of Sivantos Group, which was Siemens Audiology Solutions prior to its spin-off from Siemens AG in early 2015. Dr. Requardt has served as non-executive director of Sphere Medical Ltd., Cambridge, United Kingdom since 2018. Dr. Requardt holds a Ph.D. in Biophysics, with a focus on radiation biophysics and microbiology, from the University of Frankfurt. In addition to his global and technical industry expertise, Dr. Requardt brings to the Board significant experience in the management and strategic planning of life sciences companies. Dr. Requardt serves on our Compensation Committee and our Nominating & Governance Committee.

What is Hermann Fritz Requardt's net worth?: The estimated net worth of Hermann Fritz Requardt is at least $1.19 million as of March 4th, 2024. Dr. Requardt owns 23,147 shares of Bruker stock worth more than $1,187,441 as of November 17th. This net worth estimate does not reflect any other assets that Dr. Requardt may own. Learn More about Hermann Fritz Requardt's net worth.
How do I contact Hermann Fritz Requardt?: The corporate mailing address for Dr. Requardt and other Bruker executives is 40 Manning Road, Billerica MA, 01821. Bruker can also be reached via phone at (978) 663-3660 and via email at [email protected]. Learn More on Hermann Fritz Requardt's contact information.
Has Hermann Fritz Requardt been buying or selling shares of Bruker?: Hermann Fritz Requardt has not been actively trading shares of Bruker over the course of the past ninety days. Most recently, Hermann Fritz Requardt sold 15,000 shares of the business's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $90.06, for a transaction totalling $1,350,900.00. Following the completion of the sale, the director now directly owns 23,147 shares of the company's stock, valued at $2,084,618.82. Learn More on Hermann Fritz Requardt's trading history.
Who are Bruker's active insiders?: Bruker's insider roster includes Cynthia Friend (Director), Gerald Herman (CFO), Marc Kastner (Director), Frank Laukien (CEO), Mark Munch (VP), Richard Packer (Director), and Hermann Requardt (Director). Learn More on Bruker's active insiders.
Are insiders buying or selling shares of Bruker?: In the last year, insiders at the medical research company sold shares 1 times. They sold a total of 15,000 shares worth more than $1,350,900.00. The most recent insider tranaction occured on March, 4th when Director Hermann Fritz Requardt sold 15,000 shares worth more than $1,350,900.00. Insiders at Bruker own 28.3% of the company. Learn More about insider trades at Bruker.
Information on this page was last updated on 3/4/2024.

Hermann Fritz Requardt Insider Trading History at Bruker

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/4/2024	Sell	15,000	$90.06	$1,350,900.00	23,147

Hermann Fritz Requardt Buying and Selling Activity at Bruker

Bruker Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $51.30

$50.88

$54.53

50 Day Range

MA: $62.60

$51.30

$70.67

2 Week Range

Now: $51.30

$50.88

$94.86

Volume

1,978,983 shs

Average Volume

1,353,219 shs

Market Capitalization

$7.78 billion

P/E Ratio

24.66

Dividend Yield

0.39%

Beta

1.2

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

From Golden Crest | Ad

Click Here For Your Free Guide